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The simian hemorrhagic fever virus (SHFV) genome differs from those of other members of the family
Arterivirus in encoding two adjacent sets of four minor structural protein open reading frames (ORFs).
A stable, full-length, infectious SHFV-LVR cDNA clone was constructed. Virus produced from this clone
had replication characteristics similar to those of the parental virus. A subgenomic mRNA was identiﬁed
for the SHFV ORF previously identiﬁed as 2b. As an initial means of analyzing the functional relevance of
each of the SHFV minor structural proteins, a set of mutant infectious clones was generated, each with
the start codon of one minor structural protein ORF mutated. Different phenotypes were observed for
each ortholog of the pairs of minor glycoproteins and all of the eight minor structural proteins were
required for the production of infectious extracellular virus indicating that the duplicated sets of SHFV
minor structural proteins are not functionally redundant.
& 2014 Elsevier Inc. All rights reserved.
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Introduction
Simian hemorrhagic fever virus (SHFV) was ﬁrst identiﬁed in
the 1960s when it was found to be the causative agent of fatal
hemorrhagic fever outbreaks in captive rhesus macaque colonies
in the United States, Russia and Europe (Tauraso et al., 1968).
Experimental SHFV infections in several macaque species produced clinical symptoms including fever, anorexia, adipsia, cyanosis, skin petechial and nose bleeds and ultimately, led to death
by 7 to 13 days after infection (Allen et al., 1968; London, 1977;
Palmer et al., 1968). These symptoms closely resembled those
induced by other types of hemorrhagic fever viruses, such as Ebola
Zaire and Marburg viruses in rhesus macaques (Bray, 2005).
Various species of African monkeys are the natural hosts of SHFV,
and in baboons, vervets, patas monkeys and African green
monkeys, SHFV infections are typically asymptomatic and often
persistent (Gravell et al., 1986). Previous SHFV outbreaks in
macaque colonies are thought to have been caused by inadvertent
mechanical transfer of SHFV present in the blood of a persistently
infected African monkey to a macaque followed by efﬁcient transmission of the virus between macaques (Palmer et al., 1968). Humans
exposed to SHFV-infected macaques did not develop disease symptoms or seroconvert (Dalgard et al., 1992; Palmer et al., 1968).
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SHFV is a member of the family Arteriviridae that also includes
equine arteritis virus (EAV), porcine reproductive and respiratory
syndrome virus (PRRSV), lactate dehydrogenase elevating virus
(LDV) and wobbly possum disease virus (Dunowska et al., 2012;
Snijder and Meulenberg, 1998). The Arteriviridae, Coronaviridae
and Roniviridae families are classiﬁed within the Order Nidovirales
based on similarities in genome organization and replication
strategy (Snijder and Kikkert, 2013). The SHFV genome is a 50
capped and 30 polyadenylated, positive-sense, single-stranded RNA
of approximately 15.7 kb. The 50 two-thirds of the genome encodes
the ORF1a and ORF1ab polyproteins (Fig. 1A). The nonstructural
proteins proteolytically cleaved from these polyproteins are
required for the replication and transcription of the viral genomic
and subgenomic (sg) RNAs (Beerens et al., 2007; Snijder and
Meulenberg, 1998).
The viral structural proteins are encoded at the 30 end of the
genome and are expressed from a 30 and 50 coterminal, nested
set of sg mRNAs. The 30 most gene (ORF7) encodes the 15 kDa
nucleocapsid (N) protein which forms disulﬁde-linked homodimers that interact to form the nucleocapsid (Dea et al., 2000;
Snijder and Meulenberg, 1998). The interaction of the basic
N-terminal domain of the N protein with genomic RNA is thought
to facilitate packaging of the viral RNA into the nucleocapsid
(Dea et al., 2000). The two other major structural proteins are
the 19 kDa non-glycosylated membrane (M) protein and the
26 kDa major glycoprotein (GP5). These two virion envelopeassociated proteins interact to form disulﬁde-linked heterodimers
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that function in virion attachment (Delputte et al., 2002,2007). The
M protein is the most conserved arterivirus structural protein and
is essential for progeny virion assembly (Delputte et al., 2002;
Snijder and Meulenberg, 1998). The macrophage-restricted protein
sialoadhesion (CD169) serves as the arterivirus receptor and
mediates virion internalization (Van Breedam et al., 2010; Welch
and Calvert, 2010), while the macrophage-speciﬁc CD163 antigen
is required for virion entry/uncoating (Calvert et al., 2007; Van
Gorp et al., 2008). Recently, an additional ORF (GP5a) that starts at
an alternative AUG within the major glycoprotein GP5 ORF was
identiﬁed in the genomes of each of the known arteriviruses (Firth
et al., 2011). An EAV reverse genetic study indicated that GP5a was
not an essential protein but its absence reduced virus yields and
GP5a was detected in puriﬁed PRRSV particles (Johnson et al.,
2011; Sun et al., 2013).
The EAV, PRRSV and LDV genomes also encode four minor
structural proteins: E, GP2, GP3 and GP4. The sequences of these
proteins are less conserved between different arteriviruses than
those of the major structural proteins. The minor structural GPs
form complexes located on the surface of virions that are postulated to be involved in receptor binding and virion uncoating
(Snijder and Kikkert, 2013). The E protein is translated from
bicistronic sg mRNA 2 that also expresses GP2 and it has been
proposed that E oligomers function as ion-channels during virion
entry (Lee and Yoo, 2006; Snijder et al., 1999). The SHFV genome
encodes two adjacent sets of four minor structural protein ORFs
(Godeny et al., 1998).
A stable, full-length cDNA infectious clone for SHFV-LVR
(SHFVic) was constructed. The replication characteristics of the
virus produced by MA104 cells transfected with in vitro-transcribed SHFVic RNA were similar to those of the parental SHFVLVR virus. A separate sg mRNA was identiﬁed for the SHFV ORF
previously identiﬁed as 2b. A set of mutant infectious clones, each
lacking the expression of one of the duplicated 30 ORFs, was made
and their ability to produce infectious virions was analyzed.
The data indicate that all eight of the minor structural proteins
are required for the efﬁcient production of infectious virions and
suggest that SHFV particles are more complex than those of the
other known arterivirues.

Results
Construction of a full-length cDNA infectious clone of SHFV-LVR
A full-length cDNA clone of the SHFV, strain LVR, genome was
constructed using a previously described strategy (Fang et al.,
2006b; Nielson et al., 2003; Yount et al., 2000, 2002). Five overlapping cDNA fragments covering the genome were ampliﬁed
from SHFV RNA by RT-PCR as described in the Materials and
Methods section (Fig. 1B and C). A few nts in each fragment
differed from the Genbank SHFV consensus sequence (Accession
number AF180391.1) and initially each of these nts was corrected
by site-directed mutagenesis of the appropriate fragment clone.
The corrected individual fragment clones were then cut with
PﬂMI, simultaneously ligated and cloned into pACYC184. The
complete cDNAs in three clones were sequenced and no unexpected mutations were found. MA104 cells transfected with either
100 or 500 ng of in vitro transcribed SHFV RNA were observed
daily for the development of cytopathic effect (CPE). At 120 h after
transfection, cells were lysed and lysates analyzed for SHFV
nucleocapsid and nsp1β proteins by Western blotting. The transfected cells did not show any obvious CPE and viral proteins were
not detected in cell lysates through 120 h (data not shown). The
harvested culture ﬂuid was serially passaged four times in an

Table 1
Nucleotide differences between GenBank (AF180391.1) and SHFVic sequences.
Position

GeneBank

New sequencing

Amino acid change

Gene

511
849
1658
2503
3726
3757
3785
4277
4895
5575
5695
5704
5707
5727
6088
8276
8340
10359

C
G
G
G
C
–
A
T
A
G
G
A
C
A
G
T
G
T

T
T
A
C
–
A
G
G
G
T
A
T
G
T
C
G
T
C

P101L
V214F
silent
G765A
10 aa frame shift
10 aa frame shift
silent
silent
silent
G1889V
R2018H
K2021I
P2022R
I2029F
G1960A
S2879A
W2900L
L3373S

nsp1α
nsp1β
nsp1γ
nsp2
nsp2
nsp2
nsp2
nsp3
nsp4
nsp5
nsp5
nsp6
nsp6
nsp6
nsp7
nsp9
nsp9
nsp11

attempt to recover virus but neither CPE nor intracellular viral
protein was detected after any of these passages (data not shown).
Because the Genbank consensus sequence (GenBank Assession
number AF180391.1) of SHFV LVR was obtained by older sequencing methods from shot gun clones and it was likely that this
sequence contained deleterious errors. Viral RNA extracted from
parental SHFV LVR was subjected to 454 sequencing as described
in the Materials and Methods section. In addition, each of the
fragment clones was reampliﬁed from SHFV LVR RNA by RT-PCR
and sequenced. The same 18 nt differences compared with the
previous GenBank consensus sequence were detected by both 454
genomic sequencing and individual fragment sequencing (Table 1).
The GenBank sequence was updated based on 454 sequencing
data (GenBank Assession number AF180391.2). The reampliﬁed
fragment clones were then used to construct new full-length
clones (SHFVic). The sequences of three independently constructed full length clones were conﬁrmed. Viral RNA was
in vitro transcribed from linearized plasmid RNA and analyzed
on an RNase-free denaturing agarose gel (Fig. 1D). Six RNA bands
with sizes of about 15, 13, 12, 7, 4 and 3 kb were consistently
detected. The 15 kb band was appropriately sized to represent the
full-length viral genome RNA. The shorter products were likely the
result of premature termination or aberrant transcription. MA104
cells transfected with either 100 or 500 ng of in vitro transcribed
SHFVic RNA showed CPE by 72 h after transfection and Western
blot analysis detected nsp1β in lysates from cells transfected with
either concentration of viral RNA at 72 h after transfection
(Fig. 2A). The higher amount of viral protein detected after
transfection of 100 ng of RNA suggested the possibility that
increased amounts of the shorter RNAs negatively affected the
efﬁciency of viral replication. To conﬁrm that extracellular infectious virus was produced, 100 μl of undiluted culture ﬂuid from the
transfected cells was passaged onto fresh MA104 cells. These cells
showed CPE starting at 24 h after infection and Western blot
analysis detected intracellular nsp1β protein in cell lysates harvested at 72 h (Fig. 2A).
To compare the replication kinetics of the infectious clone virus
and the parental virus, MA104 cells were infected with either ﬁrst
passage infectious clone virus or with SHFV-LVR parental virus at
an MOI of 1 and viral yields were quantiﬁed by plaque assay on
MA104 cells at various times after infection (Fig. 2B). The replication kinetics of the parental virus and the infectious clone virus
were similar and both cultures produced peak titers of  106 PFU/
ml by 72 h after infection. The kinetics of intracellular viral protein
synthesis were assessed by Western blotting of lysates from
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Fig. 1. Construction of a full-length SHFV-LVR cDNA infectious clone. (A) SHFV genome organization. The ORFs of 15.7 kb SHFV genome are indicated by boxes. ORF1a and
ORF1ab encode the nonstructural proteins. The 1ab polyprotein is produced when a  1 ribosomal frameshift (RFS) occurs at a slippery sequence. The 30 ORFs include two
duplicated sets of minor structural protein ORFs (gray), ORF5a (gray) and three major structural protein ORFs (white). The minor structural protein ORFs are: ORF2a0 (GP20 ),
ORF2b0 (E0 ), ORF30 (GP30 ), ORF40 (GP40 ), ORF2b (E), ORF2a (GP2), ORF3 (GP3), and ORF4 (GP4). The major structural protein ORFs are: ORF5 (GP5), ORF6 (M – membrane
protein), and ORF7 (N – nucleocapsid protein). The ORF protein products are indicated in parentheses. ORF5a encodes GP5a which is thought to be an additional minor
structural protein. (B) Strategy used for SHFVic assembly. Five overlapping cDNA fragments spanning the genome were generated by RT-PCR and cloned separately into pCRXL-TOPO. (C) Assembly of the infectious SHFV clone. The ﬁve fragment pCR-XL-TOPO clones were cut with PﬂMI alone (fragments 2 and 4) or also with RsrII (fragment 3),
SpeI (fragment 1) or NotI and RsrII (fragment 5). The individual viral genome fragment bands are indicated with an asterisk. The ﬁve fragments were simultaneously ligated
and cloned into the large capacity vector pACYC184 (V) that had been cut with XbaI and EagI to pair with the SpeI sticky end of fragment 1 and the NotI sticky end of
fragment 5, respectively. (D) In vitro transcribed viral RNA was incubated with DNase, precipitated with lithium chloride, washed with ethanol and electrophoresed on an
RNase-free denaturing 2% agarose gel. An arrow indicates the full-length genome RNA and arrowheads indicate shorter RNA products in vitro transcribed from the infectious
clone cDNA.

replicate cultures. Similar kinetics of production and levels of
intracellular nsp1β and nucleocapsid were detected by Western
blotting in parental and SHFVic virus infected cell lysates (Fig. 2C).
The data indicate that the replication efﬁciency of virus derived
from the infectious clone is comparable to that of the parental
LVR virus.
Analysis of SHFV sg mRNA production in infected cells
EAV produces six sg mRNAs in infected MA104 cells (Snijder
and Meulenberg, 1998; Van Berlo et al., 1982) and sg mRNA 2 was
subsequently shown to be bicistronic expressing both GP2 and E
(Snijder et al., 1999). Because the sequence obtained for the 30 end
of the SHFV genome indicated the presence of a duplicated set of
minor structural ORFs (Godeny et al., 1998), 9 sg SHFV mRNAs
were predicted. However, evidence was obtained for only 8 due to
the lack of detection of a PCR band containing a sg mRNA junction
sequence for the second minor GP ORF (Godeny et al., 1998).

The ﬁrst and second SHFV minor GP ORFs were therefore named
ORF2a and ORF2b because it was assumed that these GPs were
expressed from a bicistronic sg mRNA (Godeny et al., 1998). The
existence of an ORF for the E' protein overlapping the ﬁrst minor
GP ORF was not known at that time.
The sg mRNAs produced by MA104 cells infected with SHFVic
virus were analyzed by Northern blotting using a DIG-labeled 5´
leader probe. The 15.7 kb genome and nine sg mRNA bands with
sizes of 5.0, 4.4, 4.0, 3.5, 2.8, 2.6, 1.9, 1.2 and 0.6 kb were detected
starting at 8 h after infection (Fig. 3A). The detection of 5.0 and
4.4 kb sg mRNAs suggested that separate sg mRNAs are expressed
for the previously named ORF2a and ORF2b. To conﬁrm that
separate sg mRNAs were expressed for these two ORFs, a set of
RT-PCR primers (Table 4) was designed that were predicted to
amplify the junction regions of both ORF2a (now ORF20 ) and
ORF2b (now ORF30 ) sg mRNAs (Fig. 3B, top). The RT-PCR products
generated from total cell RNA isolated from MA104 cells infected
with SHFVic virus for 24 h were separated on an agarose gel and
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visualized by ethidium bromide staining. A strong band of
1000 bp and a weaker PCR band of  500 bp were detected
(Fig. 3B, bottom). These bands were excised and the PCR products
present in each band were TA cloned and sequenced. The junction
sequence identiﬁed in the predominant  1000 kb band was
identical to the one previously reported for sg mRNA 2a (data
not shown) (Godeny et al., 1998). The junction sequence found in
the weaker  500 kb band is shown in Fig. 3C. Based on the
detection of the 4.4 kb sg mRNA and current knowledge that the
sg mRNA of the former ORF2a is bicistronic because it contains an
E protein ORF, the SHFV ORF formerly named ORF2b was renamed
ORF30 (Fig. 3A). To facilitate comparison of the structural ORFs
among the arteriviruses, the duplicated sets of SHFV minor
structural ORFS and proteins were renamed ORF2a0 (GP20 ), ORF2b0
(E0 ), ORF30 (GP30 ), ORF40 (GP40 ) and ORF2b (E), ORF2a (GP2), ORF3
(GP3), ORF4 (GP4) (Fig. 1A) (Snijder and Kikkert, 2013).
The relative intensities of the individual sg mRNA bands
differed with sg mRNAs 20 , 2, 5, 6, and 7 being the most abundant.
Previous Northern blot analyses of the SHFV sg mRNAs done
before it was known that the SHFV genome encoded additional
30 ORFs detected only these ﬁve strong sg mRNA bands (Godeny et
al., 1995; Zeng et al., 1995). Interestingly, the relative abundance of
the sg mRNAs for the orthologs in the duplicated sets of SHFV 3´
ORFs was similar with sg mRNAs 20 and 2 being abundantly
expressed while sg mRNAs 30 , 3, 40 and 4 were expressed at low
levels.
Analysis of the functional importance of the individual minor
structural proteins
The SHFV genome is predicted to encode two sets of minor
structural proteins while the LDV, EAV and PRRSV genomes encode
a single set (Godeny et al., 1998). Recent data indicate that all four
of the minor structural proteins of EAV and PRRSV are required for
viral attachment/entry (Snijder and Kikkert, 2013; Tian et al.,
2012). To analyze the functions of the individual SHFV minor
structural proteins, the translation start codon for each of the
8 minor structural proteins was individually mutated in the
appropriate genomic fragment clone without altering the amino
acid coded in an overlapping ORF as described in the Materials and
Methods section. Three full-length clones were then assembled for
each of the minor structural protein knock-out mutants. In vitro
transcribed viral RNA (100 ng) for each of the 3 clones was
separately transfected into MA104 cells. A replication deﬁcient
polymerase mutant (conserved SDD changed to SAA) was also
constructed and used as a negative control. Wildtype SHFVic RNA
was used as a positive control. Transfected cells were observed
daily for CPE through 120 h after tranfection. Cells transfected
with viral RNA transcribed from each of the minor structural
protein mutant clones showed no CPE by 120 h after transfection
with the exception of one of the three replicate ΔGP40 viral RNAs
which produced CPE at 72 h after transfection comparable to that
observed after transfection with the wild type SHFVic RNA. Only
the other two ΔGP40 mutants were further analyzed. Cells transfected with RNA transcribed from the SAA mutant clone also
showed no CPE. Culture ﬂuid harvested at 120 h after transfection
of the mutant RNAs was next passaged onto fresh MA104 cells and
the cells were observed daily for CPE. No CPE was observed by
120 h after the ﬁrst passage or during an additional four serial
blind passages on MA104 cells.
To determine whether extracellular viral particles were produced by any of the mutant RNA transfected cells, RNA was
extracted from culture ﬂuids harvested at various times after
transfection and the amount of viral RNA present was quantiﬁed
by qRT-PCR. Data was obtained for two independent clones for
each mutant and all samples were analyzed independently using

primers and probe sets targeting the nucleocapsid and the nsp9
regions of the genome RNA. Because very similar data were
obtained with both primer/probe sets, only the data obtained
with the nucleocapsid primers/probe set are shown. Transfection
of wildtype SHFVic RNA resulted in a large increase in extracellular
viral RNA starting at 96 h after transfection with viral RNA levels
continuing to increase through 120 h (Fig. 4A). In contrast,
transfection of SAA mutant RNA did not result in an increase in
extracellular viral RNA above background levels at any time tested.
Transfection of ΔGP20 or ΔGP30 mutant RNA did not result in an
increase in extracellular viral RNA above background levels at any
of the times analyzed (Fig. 4A and B). In contrast, an increase in
extracellular viral RNA was detected beginning at 24 h after
transfection ofΔGP40 , ΔGP2 or ΔGP3 mutant RNA indicating that
extracellular progeny particles were produced by each of these
mutants (Fig. 4C–E). A sustained low level of extracellular viral
RNA would be expected if only a single cycle infection occurred
and virus particles were produced from only the few cells transfected with a replication competent, full length copy of in vitro
transcribed mutant viral RNA. Interestingly, between 24 and 72 h,
the relative amounts of extracellular viral RNA were higher in
culture ﬂuids from cells transfected with ΔGP40 , ΔGP2, or ΔGP3
mutant RNA than in culture ﬂuids from cultures transfected with
wildtype RNA. This observation is consistent with the accumulation of non-infectious virus particles in the mutant RNA transfected culture ﬂuids. Infectious wildtype virus would not be
expected to accumulate initially due its ability to efﬁciently attach
to and enter cells. Cells transfected with ΔGP4 mutant RNA
produced increased levels of extracellular viral RNA by 24 h after
transfection than cells transfected with the wildtype RNA suggesting that the particles produced by this mutant RNA were also not
infectious (Fig. 4F). However, the level of ΔGP4 extracellular viral
RNA decreased by 48 h suggesting a possible role for GP4 in virion
stability. For each of the mutants, intracellular nsp1β levels in cell
lysates collected at 120 h after transfection and at 120 h after a
single blind passage were analyzed by Western blotting. Nsp1β
was not detected in cells transfected with any of the mutant RNAs
or in any of the passage 1 cells (Fig. 4J). The lack of detection of
intracellular viral protein is consistent with a lack of virus spread
and the levels of viral protein in the few productively transfected
cells being too low to detect by Western blotting. Mutant infectious clones were next made that had the AUGs of both GP20 and
GP2, both GP30 and GP3, or both GP40 and GP4 mutated. No CPE
was observed by 120 h after transfection with any of these double
mutant RNAs or during four subsequent serial blind passages of
the culture ﬂuids. No extracellular viral RNA was detected in
culture ﬂuids harvested from cells transfected with any of the
double mutant RNAs (Fig. 4G–I) and no detectable intracellular
nsp1β protein was detected after transfection or passage (Fig. 4K).
No CPE was observed in cells transfected with ΔE0 or ΔE mutant
viral RNA or during ﬁve subsequent serial blind passages of culture
ﬂuid. No signiﬁcant increase in extracellular viral RNA above
background levels was detected in culture ﬂuids from cells
transfected with either ΔE0 or ΔE mutant RNA (Fig. 5A and B).
No intracellular nsp1β protein was detected at 120 h after transfection or at 120 h after passage 1 (Fig. 5C). The results suggest
that both SHFV E0 and E proteins play an essential role in virus
particle production.

Discussion
The EAV, PRRSV and LDV genomes encode four minor structural
proteins, GP2, E, GP3 and GP4. The SHFV genome is unique in
having a second set of the minor structural protein ORFs that are
proposed to have been acquired by copy choice recombination
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between two SHFV genomes (Smith et al., 1997). It had also been
suggested that the minor structural protein gene sequence duplication might be a laboratory artifact unique to the SHFV LVR strain
(Tauraso et al., 1968). However, the additional set of SHFV 30 ORFs
was reported to be present in SHFV isolates recently obtained from
naturally infected Red colobus and Red-tailed guenon (Lauck et al.,
2011, 2013) and also from persistently infected baboons (Vatter
and Brinton, unpublished data).
Infectious clones for multiple strains of EAV and PRRSV have
been constructed (Balasuriya et al., 2007; Fang et al., 2006a; Lv et
al., 2008; Meulenberg et al., 1998; Nielson et al., 2003; Van Dinten
et al., 1997) and these infectious clones have been used to
investigate viral replication as well as the induction and counteraction of host immune responses. SHFVic is the ﬁrst SHFV
infectious clone and the longest arterivirus RNA genome cDNA to
date to be stably maintained within a single plasmid. The successful generation of SHFVic provides a unique tool for analyzing the
functions of individual virus proteins and for identifying SHFV
virulence determinants for macaques. In the present study, SHFVic
was used for a reverse genetics analysis of the effects of separately
knocking out the expression of each of the eight SHFV minor
structural proteins in the duplicated sets.
Data previously obtained with EAV and PRRSV indicate that
virus particles containing genome RNA are still produced when
only the major structural proteins, N, M and GP5 are expressed
(Wieringa et al., 2004a; Wissink et al., 2005; Zevenhoven-Dobbe
et al., 2004). EAV GP2 and GP4 form heterodimers through
intermolecular cysteine bridges (Wieringa et al., 2003a). After
virion release, a post-assembly maturation occurs resulting in
EAV GP3 becoming disulﬁde bonded to GP2-GP4 heterodimers
forming GP2-GP3-GP4 heterotrimers (Wieringa et al., 2003b,
2004b). GP3 of Type 2 PRRSV strains is required for formation of
the GP2/GP4 heterodimer (Dea et al., 2000). The PRRSV GP4 is
required for the interaction of GP2-GP3-GP4 heterotrimers with
the major glycoprotein GP5 (Das et al., 2010). The C-terminal
domain of PRRSV GP4 functions as a GPI anchor and expressed
GP4 colocalizes with CD163 in lipid rafts on the plasma membrane
(Du et al., 2012). The E protein appears to be associated with GP2GP3-GP4 heterotrimer on the surface of virions (Wieringa et al.,
2004a) and to function as an ion channel during virus entry (Lee
and Yoo, 2006). Knockout of the expression of GP2, GP3, GP4 or E
blocked the incorporation of the minor GP heterotrimer into virion
particles (Wieringa et al., 2003b, 2004a; Wissink et al., 2005;
Zevenhoven-Dobbe et al., 2004).
Based on sequence homology between SHFV minor structural
protein orthologs and the respective homologs of other arteriviruses, it was previously suggested that the two sets of SHFV
minor structural glycoproteins might be functionally redundant
(Godeny et al., 1998). However, in the present study different
phenotypes were detected for the ΔGP20 and ΔGP2 mutant RNAs
(Fig. 4A and D), for the ΔGP30 and ΔGP3 mutant RNAs (Fig. 4B and
E) and for the ΔGP40 and ΔGP4 RNAs (Fig. 4C an F). No extracellular viral RNA was detected when either GP20 or GP30 expression was knocked out indicating that these two proteins are
required for virion assembly, release and/or stability. However,
the possibility that one or both of these proteins may also be
involved in virion infectivity cannot be ruled out. Sustained low
levels of extracellular viral RNA were produced when GP2, GP3 or
GP40 expression was knocked out but no ampliﬁcation of the viral
RNA was detected at later times indicating that non-infectious
virus particles were produced. It is possible that these three minor
SHFV GP proteins form a complex that functions similar to the
GP2-GP3-GP4 heterotrimer of other arteriviruses. Although both
ΔGP40 and ΔGP4 mutant RNAs produced non-infectious virus
particles, the production of these particles was not sustained
when GP4 was not expressed suggesting that GP4 may play a role
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in virion particle stability. The ﬁnding that each of the SHFV minor
GPs was required for the production of infectious virions as well as
the observation of different phenotypes for the orthologs of the
two sets of SHFV minor GPs indicate that the duplicated sets of
SHFV minor structural proteins are not functionally redundant.
The LDV, EAV and PRRSV E proteins are each translated from
the bicistronic sg mRNA 2. However, the location of the start codon
of the E protein ORF relative to that of the GP2 protein ORF in sg
mRNA 2 differs among these genomes. GP2 translation is initiated
from the 50 AUG (ORF2a) and E translation is initiated at a
downstream AUG (ORF2b) in the PRRSV sg mRNA 2, whereas in
the sg mRNA 2 of LDV and EAV, the E protein is initiated from the
50 most AUG (ORF2a) and GP2 is initiated from a downstream AUG
(ORF2b). In the SHFV sg mRNA 20 , ORF2a0 (GP20 ) is upstream of
ORF2b0 (E0 ) similar to the order in PRRSV sg mRNA 2. In contrast, in
the SHFV sg mRNA 2, ORF2b (E) is upstream of ORF2a (GP2) similar
to the EAV and LDV gene order (see Fig. 1A). The E protein
sequences of EAV, PRRSV and LDV contain a conserved Nterminal myristoylation site (Thaa et al., 2009). Inhibition of
myristoylation during EAV replication decreased virus infectivity
and plaque size but not the amount of extracellular virus suggesting that myristoylation of E is not required for virion budding or
release but facilitates infectivity (Thaa et al., 2009). The SHFV E
protein sequence contains the conserved N-terminal myristoylation site but the SHFV E0 protein sequence does not. Extracellular
viral RNA was not produced by cells transfected with either ΔE0 or
ΔE mutant RNA. These data suggest that both SHFV E0 and E also
play a role in virion production/stability. Although previous
studies with EAV showed that knocking out GP2, GP3, GP4 or E
expression blocked the incorporation of the minor GP heterotrimer into virion particles, a role for E in virion assembly or stability
has not been reported (Wieringa et al., 2003b, 2004a; Wissink et
al., 2005; Zevenhoven-Dobbe et al., 2004). Additional studies are
required to determine whether SHFV E and/or E0 proteins have
functions during virus attachment and/or entry. The data obtained
indicate that each of the proteins in the duplicated sets of SHFV
minor structural proteins are required for the production of
infectious virions. Among RNA viruses, SHFV particles appear to
contain the largest number of envelop proteins.

Materials and methods
Cells and virus
The MA104 cell line was a gift from O. Nianan, Centers for
Disease Control and Prevention (Atlanta, GA). These cells were
cultured in Minimal Essential Medium (MEM) supplemented with
10% heat-inactivated fetal bovine serum and 10 μg/ml gentamicin
at 371C in 5% CO2 atmosphere.
SHFV, strain LVR 42-0/6941 (American Type Culture Collection)
was sequentially plaque-puriﬁed three times and then ampliﬁed
once on MA104 cells (MOI of 0.01) to produce a stock pool. Virus
stocks used for experiments were made by infecting conﬂuent
MA104 monolayers with the stock virus at an MOI of 0.2 and
harvesting culture ﬂuid at 32 h after infection. Clariﬁed culture
ﬂuid (  107 PFU/ml) was aliquoted and stored at  80 1C.
Generation of overlapping genomic fragments
Genomic RNA was extracted from SHFV-LVR with TRI Reagent
(Molecular Research Center, Cincinnati, OH) and 5 overlapping
cDNA fragments were synthesized using SuperScript II reverse
transcriptase (Invitrogen) and the forward primers listed in
Table 2. The fragment junctions were selected based on the
locations of PﬂMI recognition sequences (CCANNNN/NTGG). Each
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Table 2
Primers used to generate overlapping cDNA fragments from SHFV-LVR RNA.
Primer
Fragment 1
F-SP6–1
R-2343
Fragment 2
F-2307
R-7991
Fragment 3
F-7858
R-12306
Fragment 4
F-12190
R-12983
Fragment 5
F-12662
R-15717
a
b

Sequence (50 –30 )

act agt ATT TAG GTG ACA CTA TAG ATT AAA ATA AAA GTG TGA AGC
CAA CCA CCC AAT GGT CAG AGT CAA GG

a, b

TAC GTT GTG CGC CTT GAC TCT GAC
GCT TGC CAG ACA GAA ATT TGA GAC TG
TGG TCT CTC CTC AGG TGA TC
AGT CAT GTT GCC TGT AAT TGT CTC
TAT GTC TAT CGT CCA CCA CTT GTC
AGG TAT TTA GAA AGT CCA GTC ACG
TCT GCT GGT TGG TAA AAT GCT CTC ACT CAC
gcg gcc gcc gat cgt (T)42 AAT TAT GGT ATA b

SP6 promoter consensus sequence is indicated by underlining.
Recognition sites for restriction enzymes SpeI in F-SP6-1 and NotI and PvuI in R-15717 are in lowercase.

fragment cDNA was then ampliﬁed by PCR using an appropriate
set of primers (Table 2). Cycling conditions were 48 1C for 30 min,
94 1C for 2 min, then 37 cycles of 94 1C for 30 s, 55 1C for 30 s and
65–72 1C for 1–5 min followed by a ﬁnal cycle at 72 1C for 7 min to
facilitate subsequent TA cloning. A unique SpeI cutting site (for
insertion into the pACYC184 vector) and the SP6 promoter were
added to the 50 end of fragment 1 in the forward primer and a
47 nt poly A tail, a unique PvuI site (for linearization) and a unique
NotI site (for insertion into the pACYC184 vector) were added to
the 30 end of fragment 5 in the reverse primer (Table 2). Each of
the PCR fragments was gel puriﬁed and cloned into the pCR-XLTOPO vector. These plasmids were maintained in TOP10 or INV110
Escherichia coli cells (Invitrogen) grown in LB media containing
kanamycin (50 mg/ml). Multiple clones of each fragment were
generated and sequenced.

serum-free Opti-MEM (Gibco). The in vitro transcribed infectious
clone RNA (100 or 500 ng) was mixed with 10 μl DMIRE-C (1,
2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl ammonium bromide and cholesterol) (Invitrogen) in serum-free Opti-MEM
(Gibco) and added to the cells. DMIRE-C without RNA was used
as a negative control and DMIRE-C with RNA extracted with TRI
Reagent from parental SHFV-LVR virions was used as a positive
control. The transfection media was removed after 4 h and 2 ml of
fresh media were added to each well. Culture ﬂuid (100 μl)
harvested at 120 h was used to infect a fresh MA104 cell monolayer. This procedure was repeated for a total of three or four serial
passages. In some cases, the harvested culture ﬂuid was analyzed
for viral RNA by qRT-PCR and cell lysates were analyzed for the
presence of SHFV nucleocapsid and nsp1β proteins by Western
blotting.

Assembly of full-length cDNA clones
454 sequencing of viral RNA
Plasmid DNA of each fragment was digested with PﬂMI alone
(fragments 2 and 4) or also with SpeI (fragment 1), RsrII (fragment
3) or NotI and RsrII (fragment 5). The pACYC184 vector was
digested with XbaI and EagI to generate cohesive ends that were
compatible with SpeI and NotI, respectively, and then gel puriﬁed.
The digested SHFV cDNA fragments and vector DNA were simultaneously ligated using a T4 Rapid Ligation kit (Thermo Scientiﬁc)
and the resulting DNA was used to transform XL10-Gold KanR
Ultracompetent cells (Stratagene). The cells were grown overnight
at 37 1C in LB media containing chloramphenicol. The full-length
SHFV cDNA clones generated were sequenced to insure that no
mutations had occurred during cloning.
In vitro RNA transcription and cell transfection
Full-length cDNA clones were linearized with PvuI, puriﬁed on
MinElute columns (Qiagen) and used as templates for in vitro
transcription of capped mRNA using a mMessage mMachine kit
(Ambion) according to the manufacturer's protocol. Reactions
were incubated at 37 1C for 2 h then with DNase for 15 min,
followed by LiCl precipitation and an ethanol wash of the pelleted
RNA. The ﬁnal RNA pellet was resuspended in nuclease-free dH2O.
An aliquot of the RNA was denatured with a formamide-based
RNA sample buffer (Ambion) and analyzed for size and quality on
an RNase-free denaturing gel.
MA104 cells were seeded in a six-well plate and grown overnight to o50% conﬂuency. The cells were washed once with

Viral RNA was isolated from SHFV-LVR and processed as
previously described (Donaldson et al., 2010). Brieﬂy, culture ﬂuid
was ﬁrst passed through a 0.45 μm ﬁlter to remove large contaminants and then centrifuged at 50,000  g for 2 h. The pellets
were resuspended in PBS overnight at 4 1C and then treated with
DNase Turbo, Benzonase, and RNase One for 2 h at 37 1C to remove
any RNA and DNA that was not protected due to being inside a
virion. Virion RNA was then extracted using a Qiagen Viral RNA kit
(Qiagen, Valencia, CA) according to manufacturer's instructions.
Extracted RNA was reverse transcribed, puriﬁed, and ampliﬁed as
described previously (Donaldson et al., 2010). Brieﬂy, the RNA was
reverse transcribed with Superscript III (Life Technologies, Grand
Island, NY) according to manufacturer's instructions using random
hexamers with a unique barcode. A Klenow reaction was preformed to generate dsDNA from the cDNA. The DNA was then
incubated with phosphatase and exonuclease to remove phosphates and unincorporated primers or single stranded bases,
respectively. A total of 10 μl from the Klenow reaction was used
as template for random ampliﬁcation using the unique barcode,
without the random hexamer portion, as a primer. The SISPA
reactions were gel puriﬁed using a QiaQuick Gel Extraction Kit
(Qiagen, Valencia, CA). The puriﬁed DNA samples were submitted
to the University of North Carolina High Throughput Sequencing
facility for sequencing using the Roche 454 Life Science FLX
Titanium chemistry (454 Life Sciences of Roche, Branford, CT) for
the ﬁrst sequence run. The second sequence run used the Roche
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Fig. 2. Comparison of the replication kinetics of parental and infectious clone viruses. (A) Western blots of cell lysates collected after viral RNA transfection or infection.
MA104 cells were transfected with 0, 100 or 500 ng of RNA in vitro transcribed from the SHFV infectious clone cDNA. Culture ﬂuid was collected 72 h after transfection and
100 μl were used to infect a fresh MA104 monolayer. Passage 1 culture ﬂuid was harvested after 72 h. Viral protein was detected with anti-nsp1β protein antibody. (B) Virus
yields produced by MA104 cells infected at an MOI of 1 with either parental or Passage 1 SHFVic virus. Virus yields were quantiﬁed by plaque assay on MA104 cells. (■)
Parental virus. (●) SHFVic virus. Data points are average values from three independent experiments. Each virus titration was done in duplicate. Error bars represent standard
deviation (SD). n Virus titers in the 1 and 6 h samples were below detection ( o 100 PFU/ml). (C) Time course of intracellular nsp1β and nucleocapsid protein production in
MA104 infected with parental or SHFVic virus (MOI of 1). Proteins were detected in cell lysates by Western blotting using viral protein speciﬁc antibodies. The blots shown in
panels A and C are representative of three independent experiments. Actin was used as a loading control.

Fig. 3. Analysis of sg mRNAs produced by MA104 cells infected with SHFVic virus. (A) Northern blot analysis of viral sg mRNAs. MA104 cells were mock infected (M) or
infected with SHFVic virus at an MOI of 1 and total RNA was extracted at 4, 8 16 or 24 h after infection. Cell RNA (1 μg) was electrophoresed on a 1% denaturing agarose gel,
transferred to an Hybond-N þ membrane and hybridized with a DIG-labeled 5' leader RNA probe. The sg mRNAs were identiﬁed based on size. (B) Top – Diagram indicating
the positions of the RT-PCR primers used. Bottom – Cell RNA was extracted from MA104 cells 24 h after infection with SHFVic virus at an MOI of 1 and subjected to RT-PCR.
The PCR products were separated on a 2% agarose gel. The predominant  1000 and  500 bp DNA bands were excised and the extracted DNA was TA cloned and sequenced.
(C) The junction sequence for sg mRNA 30 obtained from the  500 bp band was aligned with the genome and 50 leader sequences.

454 Junior platform and chemistry (454 Life Sciences of Roche,
Branford, CT).
Sequences derived from Roche 454 sequencing were binned
based on the barcode sequence added during the SISPA preparation, and the barcode sequences were trimmed from the reads in
each unique bin, representing individual samples. Each sample bin
was mapped to the SHFV reference genome (accession no.
AF180391.1) using the CLC Genomics Workbench version 5.1
(CLCBio, Aarhus, Denmark; http://www.clcbio.com) using default
settings. Consensus sequences were determined for each contig
using the 50% majority rule. The 454 sequence bins for each
sample were also assembled by de novo assembly to determine if
the two assembly approaches produced similar results and to
identify sequences of unknown identity. The consensus sequences

derived by de novo assembly were used to query the nonredundant nucleotide database using BLAST within the CLC Genomics Workbench interface. Differences between the reference
genome and the genome derived by sequencing were annotated
using a multiple sequence alignment generated using the CLC
Genomics Workbench.
Construction of minor structural protein knock out mutants
To generate individual mutant infectious clones that did not
express one of the eight minor structural proteins and primers
were designed to mutate the start codon of one ORF without
changing the amino acid sequence of the protein expressed
from an overlapping ORF (Table 3). Mutations were introduced
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Fig. 4. Effects of knocking out the expression of individual minor structural glycoprotein ORFs on extracellular viral RNA levels. (A–I) Analysis of extracellular viral RNA
levels. Culture ﬂuids were harvested at the indicated times after transfection with 100 ng of wildtype (gray bars), replication defective SAA mutant (white bars) or (A) ΔGP20 ,
(B) ΔGP30 , (C) ΔGP40 , (D) ΔGP2, (E) ΔGP3, (F) ΔGP4, (G) ΔGP20 /2, (H) ΔGP30 /3 or (I) ΔGP40 /4 mutant (black bars) in vitro transcribed viral RNA. Extracellular viral RNA was
extracted from 200 ul of harvested culture ﬂuid and then quantiﬁed by qRT-PCR using nucleocapsid region primers and probe and a standard curve generated with a known
amount of in vitro transcribed viral RNA. Each sample was assayed in triplicate. Error bars represent SD. Values shown are representative of two independent experiments.
The complete range of values for the extracellular wildtype viral RNA levels produced is shown only in panel A. (J and K) Western blots of MA104 cell lysates collected 120
after transfection with the indicated in vitro transcribed viral RNA or 120 h after a blind passage infection. Viral proteins were detected with anti-nsp1β antibody. The blots
shown are representative of data from three independent experiments. Actin was used as a loading control.
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Fig. 5. Effects of knocking out the expression of the SHFV E' or E protein ORF on extracellular viral RNA levels. (A and B) Analysis of extracellular viral RNA levels. Culture
ﬂuids were harvested at the indicated times after transfection with 100 ng of wildtype (gray bars), replication defective SAA mutant (white bars) or (A) ΔE0 or (B) ΔE mutant
(black bars) in vitro transcribed viral RNA. Extracellular viral RNA was extracted from 200 ul of harvested culture ﬂuid and then quantiﬁed by qRT-PCR using nucleocapsid
region primers and probe and a standard curve generated with a known amount of in vitro transcribed viral RNA. Each sample was assayed in triplicate. Error bars represent
SD. Values shown are representative of two independent experiments. The complete range of values for the extracellular wildtype viral RNA levels produced is shown only in
panel A. (C) Western blots of MA104 cell lysates collected 120 after transfection with the indicated in vitro transcribed viral RNAs or 120 h after a blind passage infection. Viral
proteins were detected with anti-nsp1β antibody. The blots shown are representative of data from three independent experiments. Actin was used as a loading control.

Table 3
Primers used to make the minor structural protein knockout mutants.
Primer sequence (50 –30 )

ORF (gene)
ORF2a0 (GP20 )
ORF2b0 (E0 )
ORF30 (GP30 )
ORF40 (GP40 )
ORF2b (E)
ORF2a (GP2)
ORF3 (GP3)
ORF4 (GP4)

F
R
F
R
F
R
F
R
F
R
F
R
F
R
R
F

CCCTCTCCTCTGcTGAGTTTCTGTCCAGG
CCTGGACAGAAACTCAgCAGAGGAGAGGG
CACTTCTCCTCCTCCTTCAAGTACTAcGATCACACCCACATTCATACTG
CAGTATGAATGTGGGTGTGATCgTAGTACTTGAAGGAGGAGGAGAAGTG
GAAGGAGAGTTCTGTACCcTGGTTTCAACTTGGTTTC
GAAACCAGATTGAAACCAgGGTACAGAACTCTCCTTC
CCTAACAATCAAGCAATCcTGGAACGAGACAATGATG
CATCATTGTCTCGTTCCAgGATTGCTTGATTGTTAGG
CGATCTTTAGAGCATTCTATTCTTAgTGGGTTCTATACTCACCCACATC
GATGTGGGTGAGTATAGAACCCAcTAAGAATAGAATGCTCTAAAGATCG
GCCTTCCACCAcGCTGTCCACGAGCTCC
GGAGCTCGTGGACAGCgTGGTGGAAGGC
CAGTTATCTCACTAACCCcTGGATGTCCGTGG
CCACGGACATCCAgGGGTTAGTGAGATAACTG
CCAGTTTGATAACGAGACATTcTGCTACATTGCAAACCTTAC
GTAAGGTTTGCAATGTAGCAgAATGTCTCGTTATCAAACTGG

Effects of the mutations on an overlapping ORF
CTCTGcTGAGT (ORF2a0 ): ATG to CTG (knock out start codon)
TACTAcGATCA (ORF2b0 ): ATG to ACG (knock out start codon)
TACTAcGATCA (ORF2a0 ): TAT to TAC (Tyrosine to Tyrosine)
GTACCcTGGTT (ORF30 ): ATG to CTG (knock out start codon)
GTACCcTGGTT (ORF2a0 ): CCA to CCC (Proline to Proline)
CAATCcTGGAA (ORF40 ): ATG to CTG (knock out start codon)
CAATCcTGGAA (ORF30 ): TCA to TCC (Serine to Serine)
TCTTAgTGGGT (ORF2b): ATG to GTG (knock out start codon)
TCTTAgTGGGT(ORF40 ): TAA to TAG (STOP codon to STOP codon)
CACCAcGCTGT (ORF2a): ATG to ACG (knock out start codon)
CACCAcGCTGT (ORF2b): CAT to CAC (Histidine to Histidine)
AACCCcTGGAT (ORF3): ATG to CTG (knock out start codon)
AACCCcTGGAT (ORF2a): CCA to CCC (Proline to Proline)
ACATTcTGCTA (ORF4): ATG to CTG (knock out start codon)
ACATTcTGCTA (ORF3): TTA to TTC (Leucine to Leucine)

using the appropriate primer set (Table 3), infectious clone
fragment [Fragment 3 for ORFs 2a0 (ΔGP2), 2b0 (ΔE0 ) and 3 0
(ΔGP3 0 ), Fragment 4 for ORF40 (ΔGP4 0 ) and Fragment 5 for
ORF2b (ΔE), 2a (ΔGP2), 3 (ΔGP3) and 4 (ΔGP4)] and a QuikChange Lightning Site-Directed Mutagenesis kit (Agilent Technologies) according to manufacturer's protocol. Brieﬂy, wild
type fragment constructs were subjected to PCR using the

mutagenic primers, the PCR products were then digested with
DpnI to cleave the parental methylated and hemimethylated
templates, and the mutant fragment DNAs were transformed
into XL10-Gold ultra-competent cells. The mutations and fragment sequences were conﬁrmed by sequencing. One mutant
fragment and four wildtype fragments were then digested
with the appropriate restriction enzymes, simultaneously
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assembled, and cloned into the pACYC184 vector as described
above. The resulting plasmid was used to in vitro transcribe
mutant genome RNA for transfection into MA104 cells.

dilution, Roche) and then with CDP-Star (Roche). The signal was
detected with an LAS4000 mini Luminescent Image Analyzer (GE
Healthcare). Spot intensities were determined using Multi Gauge
V2.3 software.

Plaque assay
Plaque assays were performed on conﬂuent monolayers of
MA104 cells in six-well plates. Harvested culture ﬂuids were
clariﬁed by centrifugation at 1000 rpm for 5 min at 4 1C, serially
diluted 10 fold in growth media and 100 μl of each dilution was
added per well. Each sample was assayed in duplicate. After
adsorption for 1 h at room temperature, the inoculum was
removed, 2 mls of overlay media [1% SeaKem ME agarose
(Bio-Whittaker Molecular Applications) mixed 1:1 with
2  MEM containing 5% FCS] were added per well and plates
were incubated at 37 1C for 72 h. After removal of the agarose
plugs, cells were stained with 0.05% crystal violet in 10%
ethanol.
Western blot
Culture media was removed from infected MA104 monolayers in 6 well plates and RIPA buffer (1  phosphate-buffered
saline, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1%
SDS) containing Halt protease inhibitor cocktail (Thermo Scientiﬁc) was added to lyse the cells. Lysate proteins were separated
by SDS-PAGE and then transferred to a nitrocellulose membrane by electrophoresis. Membranes were blocked with
1  Tris-buffered saline (TBS), pH 8.0, containing 5% non-fat
dry milk and 0.1% Tween 20 before incubation with a polyclonal
primary antibody speciﬁc for an SHFV nucleocapsid peptide
(NETHYVFAEPGDLRC), an SHFV nsp1β peptide (FAQKVITAFPEGVLC) or actin (C-11; Santa Cruz Biotechnology, Santa Cruz,
CA) in the presence of blocking buffer. Blots were washed with
1  TBS and incubated with secondary antibody (horseradish
peroxidase-conjugated anti-rabbit or anti-mouse; Santa Cruz
Biotechnology) and then processed for chemiluminescence
using a Super-Signal West Pico detection kit (Pierce, Rockford,
IL) according to manufacturer's protocol.
Digoxigenin (DIG)-labeled SHFV 50 leader probe
PCR primers were designed to amplify a region in the 50 -leader
(genome nts 7–200) for use as a template for making a 50 -leader
probe (Table 4). The reverse primer included a T7 promoter. The
PCR product generated was validated by sequencing and then
in vitro transcribed with T7 RNA polymerase in the presence of
DIG-labeled UTP using a DIG Northern Starter Kit (Roche) according to the manufacturer's protocol. The concentration of the DIGlabeled probe was determined by a dot-blot assay using dilutions
of a DIG-labeled human actin RNA probe of known concentration
as a reference (Roche). Brieﬂy, 1 μl of each dilution was spotted
onto an Amersham Hybond-N þ membrane (GE Healthcare) and
then UV-crosslinked. The membrane was blocked with DIG blocking solution (Roche), incubated with anti-DIG antibody (1:10,000

Northern blot hybridization
MA-104 cell monolayers in 6 well plates were either mock
infected or infected with SHFV infectious clone virus at an MOI of
1. At different times after infection, total cell RNA was extracted
with TRI reagent (Molecular Research Center, Inc.). One μg of RNA
was mixed with NorthernMax formaldehyde loading dye
(Ambion), denatured at 80 1C for 10 min and then separated on
1% formaldehyde agarose gel for 2.5 h at 100 V. RNA markers
(Millennium Markers-Formamide, Ambion) were run on one lane
of the gel. RNA was transferred overnight by capillary action onto
an Amersham Hybond-N þ membrane (GE Healthcare) and the
RNA was then UV-crosslinked to the membrane. The lane containing RNA standards was cut from the membrane and stained with
methylene blue. The rest of the membrane was pre-hybridized
with DIG Easy Hyb buffer (Roche) at 68 1C for 30 min and then
hybridized with 100 ng/mL of a DIG-labeled, denatured RNA probe
at 68 1C overnight. The hybridized membrane was washed ﬁrst
with low stringency buffer (2  SSC þ0.1% SDS) at room temperature, then with high stringency buffer (0.1  SSC þ 0.1% SDS) at
68 1C followed by blocking with DIG blocking solution (Roche). To
detect the RNA bands, membranes were incubated with anti-DIG
antibody (1:10,000 dilution) (Roche), developed with CDP-Star
(Roche) and imaged with an LAS4000 mini Luminescent Image
Analyzer (GE Healthcare).

Analysis of extracellular viral RNA by quantitative real-time RT-PCR
RNA in 200 μl of culture ﬂuid harvested from infectious clone
transfected MA104 monolayers was extracted with TRI Reagent.
Reaction mixtures contained extracted RNA, the primer pair
(1 μM) and probe (0.2 μM) in a ﬁnal volume of 10 μl. Primer/probe
sequences targeted either the nucleocapsid (forward primer 50 tcccacctcagcacacatca-30 , TaqMan probe 50 -6FAMaacagctgctgatcaggtMGBNFQ-30 and reverse primer 50 -ccgcctccgttgtcgtagt-30 ) or
helicase (nsp9) (forward primer 50 -cgtacacccgccgtctgct-30 , TaqMan
probe 50 -6FAMttgacgttctcacaaaggMGBNFQ-30 , and reverse primer
50 -cggcaagtggcatccaa-30 ) regions. Quantitative real time RT-PCR
was performed and the data were analyzed as previously
described (Scherbik et al., 2006). Extracellular SHFV genomic
RNA was quantiﬁed using a standard curve generated with serial
dilutions of a known concentration of SHFV RNA that had been
in vitro transcribed with a MAXIscript SP6 transcription kit
(Ambion) from either the nucleocapsid or nsp9 gene region of
the SHFVic cDNA, digested with DNase, extracted with phenolchloroform, precipitated with ethanol and then quantiﬁed by UV
spectrophotometry.

Table 4
Primers used to generate a 50 leader probe and for sg mRNA 20 and 30 ampliﬁcation.
Primer

Sequence (50 –30 )

50 -leader-probe-F
50 -leader-probe-R
50 -Leader-RT-PCR-F
sg mRNAs20 and 30 –RT-PCR-R

AATAAAAGTGTGAAGCTCCCTGTGCTTTCATGCCAGG
CGGTAGTAATACGACTCACTATAGGGTCTGCAAATCCCAAGCCAC
TAGCCCGGATTGGATAAGC
CGTAGGTGAGAATGATGG
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